MCDA methodology in the Farmacia Hospitalaria journal
Today, we are pleased to share with you the publication of our latest work using [...]
Alicia Gil, CEO Omakase Consulting attended a session held in the Spanish National Congress organised by FEDER (Spanish Rare Diseases Organisation)
Alicia Gil, CEO Omakase Consulting attended yesterday a session held in the Span [...]
The new update in the information system BIFIMED from the Spanish Ministry of Health
The Spanish Ministry of Health has updated the information system BIFIMED, an in [...]
Omakase Consulting keeps growing!
We have opened new offices in #Madrid. We inaugurate this new space with great e [...]
The AEMPS, recognised with the 2021 Public Health Figure award granted by Fundamed & Wecare-u
The Spanish agency of medicines, the AEMPS, has been recognised for their work t [...]
Revalmed Coordination Group meeting May 2021
We are glad to inform you about the Revalmed Coordination Group regular meeting [...]
Updated Annual Report on Orphan Drugs authorised in Spain and approved by the European Commission between 2003 & 2020
We are proud to announce the release of the annual update of the "Report on Orph [...]
Alicia Gil, miembro de SWL
Como CEO de Omakase Consulting y profesional vinculada durante toda mi carrera a [...]
The Omakase community grows to 1000 followers!
Omakase is pleased to share we reached 1000 followers on LinkedIn! This is a mus [...]
Dr Poveda and Dr Badia tell us how to use the Orphan Drugs Horizon Scanning report in Spain
https://gacetamedica.com/politica/la-sefh-publica-la-segunda-revision-de-medicam [...]